PKU HealthCare Corp., Ltd.

隶属于 southwest synthetic pharmaceutical co., ltd.

The company's predecessor was Southwest Synthetic Pharmaceutical Factory, founded in 1965, and successfully listed on the Shenzhen Stock Exchange in 1997. The company has built a nationwide pharmaceutical sales network covering everything from drug sales, pharmaceutical distribution, hospital collection to supply chain hosting. In the future, the company will strive to build a nationally leading generic pharmaceutical technology enterprise integrating raw materials and formulations, and become a pharmaceutical listed company with an important influence in the Chinese pharmaceutical industry. The company is mainly engaged in R&D, production and sales of chemical preparations, pharmaceutical distribution, and medical services. The company's main products: injectable ceftriaxone, meropenem for injection, cefaminol sodium hydrochloride, clindamycin palmitate granules, buspirone hydrochloride tablets, naphthymidone capsules, celecoxib capsules, dexketoprofen tablets, dexketoprofen capsules, buspirone hydrochloride tablets, olanzapine tablets. Corporate honors: A national technology center, a key Chinese pharmaceutical enterprise, a national innovative pilot enterprise, a key high-tech enterprise of the National Torch Program, etc.